Skip to content

4Accepted Jul 20, 4:34 PM ET

Versant Venture Capital V (Canada), LP 4

CRNXCrinetics Pharmaceuticals, Inc.

Accepted (ET)

4:34 PM

Jul 20, 2018

Filed

Jul 20, 2018

Documents

1

Size

44.5 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.